85 related articles for article (PubMed ID: 21661183)
1. [Lowering blood pressure and glucose reduces renal events in type 2 diabetes; ADVANCE study].
Koya D
Nihon Rinsho; 2010 Nov; 68 Suppl 9():455-60. PubMed ID: 21661183
[No Abstract] [Full Text] [Related]
2. Management of high blood pressure in type 2 diabetes: perindopril/indapamide fixed-dose combination and the ADVANCE trial [corrected].
Ghiadoni L
Expert Opin Pharmacother; 2010 Jul; 11(10):1647-57. PubMed ID: 20518617
[TBL] [Abstract][Full Text] [Related]
3. The ADVANCE trial: clarifying the role of perindopril/indapamide fixed-dose combination in the reduction of cardiovascular and renal events in patients with diabetes mellitus.
Waeber B; de la Sierra A; Ruilope LM
Am J Cardiovasc Drugs; 2009; 9(5):283-91. PubMed ID: 19791837
[TBL] [Abstract][Full Text] [Related]
4. [Type 2 diabetes: blood pressure lowering to 135/75 mmHg reduces mortality].
Einecke D
MMW Fortschr Med; 2007 Sep; 149(38):18. PubMed ID: 18018407
[No Abstract] [Full Text] [Related]
5. ADVANCE: breaking new ground in type 2 diabetes.
Chalmers J; Perkovic V; Joshi R; Patel A
J Hypertens Suppl; 2006 Aug; 24(5):S22-8. PubMed ID: 16936533
[TBL] [Abstract][Full Text] [Related]
6. [Clinical trial of the month. ADVANCE: improved survival and better vascular and renal outcomes with a fixed combination of perindopril and indapamide in patients with type 2 diabetes].
Scheen AJ; Krzesinski JM
Rev Med Liege; 2007 Oct; 62(10):639-43. PubMed ID: 18069576
[TBL] [Abstract][Full Text] [Related]
7. Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
Waeber B
J Hypertens Suppl; 2006 May; 24(3):S19-27. PubMed ID: 16723862
[TBL] [Abstract][Full Text] [Related]
8. Hypertension arm of ADVANCE defines extent of renal protection using perindopril/indapamide in type 2 diabetics.
Cardiovasc J Afr; 2008; 19(4):226. PubMed ID: 18776973
[No Abstract] [Full Text] [Related]
9. Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease.
Heerspink HJ; Ninomiya T; Perkovic V; Woodward M; Zoungas S; Cass A; Cooper M; Grobbee DE; Mancia G; Mogensen CE; Neal B; Chalmers J;
Eur Heart J; 2010 Dec; 31(23):2888-96. PubMed ID: 20501479
[TBL] [Abstract][Full Text] [Related]
10. [Nephroprotection diabetes mellitus type 2: lessons from the ADVANCE trial].
Nedogoda SV
Kardiologiia; 2011; 51(12):57-9. PubMed ID: 22304318
[TBL] [Abstract][Full Text] [Related]
11. [ADVANCE: a morbidity mortality study of diabetes and hypertension].
Heim A; Feihl F; Waeber B
Rev Med Suisse; 2008 Jan; 4(139):28, 30, 32-3. PubMed ID: 18251212
[TBL] [Abstract][Full Text] [Related]
12. Urinary N-acetyl B glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination.
Basturk T; Altuntaş Y; Kurklu A; Aydin L; Eren N; Unsal A
Ren Fail; 2006; 28(2):125-8. PubMed ID: 16538969
[TBL] [Abstract][Full Text] [Related]
13. Very-low-dose combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide induces an early and sustained increase in neovascularization in rat ischemic legs.
Silvestre JS; Kamsu-Kom N; Clergue M; Duriez M; Lévy BI
J Pharmacol Exp Ther; 2002 Dec; 303(3):1038-43. PubMed ID: 12438525
[TBL] [Abstract][Full Text] [Related]
14. [Newly diagnosed hypertensive. It calls for treatment immediately with a combination ].
MMW Fortschr Med; 2003 Nov; 145(45):48. PubMed ID: 14712787
[No Abstract] [Full Text] [Related]
15. [Vascular impact of anti-hypertensive treatment and renal protection].
Mogensen CE
Curr Med Res Opin; 2005; 21 Suppl 5():S23-8. PubMed ID: 16197649
[TBL] [Abstract][Full Text] [Related]
16. [PROGRESS--a trial on blood pressure lowering after stroke and TIA. ACE inhibitors and diuretics reduce the risk of new stroke].
Terént A
Lakartidningen; 2002 May; 99(20):2286-8, 2291. PubMed ID: 12082946
[No Abstract] [Full Text] [Related]
17. [Antihypertensive therapy in diabetic patients. What do the new data mean for the practice?].
Holzgreve H
MMW Fortschr Med; 2007 Sep; 149(38):19. PubMed ID: 18018408
[No Abstract] [Full Text] [Related]
18. Trials that matter: the effect of a fixed-dose combination of an Angiotensin-converting enzyme inhibitor and a diuretic on the complications of type 2 diabetes.
Bakris GL; Berkwits M
Ann Intern Med; 2008 Mar; 148(5):400-1. PubMed ID: 18316758
[No Abstract] [Full Text] [Related]
19. Fixed combination of perindopril and indapamide at low dose improves endothelial function in essential hypertensive patients after acute administration.
Joannides R; Bellien J; Thurlure C; Iacob M; Abeel M; Thuillez C
Am J Hypertens; 2008 Jun; 21(6):679-84. PubMed ID: 18443573
[TBL] [Abstract][Full Text] [Related]
20. Perindopril + indapamide: new preparation. Simple trick.
Prescrire Int; 1999 Dec; 8(44):172-5. PubMed ID: 11503814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]